Noradrenergic dysfunction and antidepressant treatment response

By Correa H.   Duval F.   Claude M.M.   Bailey P.   Tremeau F.   Diep T.S.   Crocq M.-A.   Castro J.O.   Macher J.-P.  

European Neuropsychopharmacology, Vol. 11, Iss. 2, 2001-04 ,pp. : 163-168

Elsevier

Access to resources Recommend Favorite

The role of noradrenaline and selective noradrenaline reuptake inhibition in depression

By Brunello N.   Mendlewicz J.   Kasper S.   Leonard B.   Montgomery S.   Nelson J.C.   Paykel E.   Versiani M.   Racagni G.  

European Neuropsychopharmacology, Vol. 12, Iss. 5, 2002-10 ,pp. : 461-475

Elsevier

Access to resources Recommend Favorite

Serotonin Reuptake Inhibition: An Update on Current Research Strategies

By  

Current Medicinal Chemistry, Vol. 9, Iss. 8, 2002-04 ,pp. : 799-810

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment response to serotonin reuptake inhibitors in minor depressions

By Rosenbaum J.F.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 172-173

Elsevier

Access to resources Recommend Favorite

Fluoxetine, a selective serotonin reuptake inhibitor modulates inflammatory and neuropathic pain in the rat

By Pal Singh Vijay   Jain Naveen K.   Kulkarni S. K.  

Inflammopharmacology, Vol. 9, Iss. 3, 2001-06 ,pp. : 219-228

VSP

Access to resources Recommend Favorite